Vectibix 100mg Injection Wholesale USA: Ernest Impex – Verified India Exporter

Vectibix 100mg Injection – Targeted EGFR Therapy | Global Bulk Supply by Ernest Impex

Vectibix 100 mg (Panitumumab) is a sophisticated recombinant human IgG2 monoclonal antibody used in the advanced treatment of metastatic colorectal cancer (mCRC). As a premier pharmaceutical exporter from India, Ernest Impex (Group of Ernest Pharmaceutical Pvt. Ltd.) provides specialized cold-chain logistics and bulk distribution to healthcare institutions in Washington (USA), London (UK), Canberra (Australia), Bangkok (Thailand), Kingston (Jamaica), and Singapore.

Comprehensive Product Information: Vectibix 100mg

1. Composition and Classification

• Active Ingredient: Panitumumab (100 mg/5 mL per vial).

• Drug Class: Epidermal Growth Factor Receptor (EGFR) Inhibitor.

• Mechanism: Vectibix is a fully human monoclonal antibody. It binds specifically and with high affinity to the EGFR on both normal and tumor cells. This binding inhibits the activation of several intracellular signaling pathways associated with cell proliferation and survival.

2. Therapeutic Indications

Vectibix 100 mg is indicated for the treatment of patients with wild-type RAS (both KRAS and NRAS) metastatic colorectal cancer:

• First-line Treatment: In combination with FOLFOX or FOLFIRI chemotherapy regimens.

• Monotherapy: For patients who have experienced disease progression following treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy.

• Genetic Requirement: It is essential that patients have a confirmed "wild-type RAS" status, as the medication is not effective in tumors with RAS mutations.

3. Administration & Dosage Guide

• Recommended Dose: The standard dose is 6 mg/kg administered once every 14 days.

• Infusion Protocol: Administered as an intravenous (IV) infusion via an infusion pump.

• Preparation: Must be diluted in 0.9% sodium chloride. It should not be administered as an IV bolus or push.

• Duration: Typically, the infusion takes 60 to 90 minutes.

4. Safety Profile & Side Effects

• Dermatologic Reactions: Common side effects include an acne-like rash, dry skin, pruritus (itching), and paronychia (nail bed inflammation).

• Electrolyte Imbalance: Can lead to low magnesium levels (hypomagnesemia). Regular monitoring of serum magnesium and calcium is required.

• Infusion Reactions: Rare but potentially serious; monitoring during and after infusion is standard practice.

• Photosensitivity: Patients should limit sun exposure, as UV light can exacerbate skin reactions.

5. Storage and Cold-Chain Logistics

• Temperature: Must be stored in a refrigerator at 2°C to 8°C.

• Handling: Do not freeze or shake. Keep the vial in the original carton to protect it from light.